pdating Our Understanding of Pulmonary Disease Associated ith HIV Infection

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Severe 2009 pandemic influenza A (H1N1) infection and increased mortality in patients with late and advanced HIV disease

  2011cited by this paper
• Human Immunodeficiency Virus Infection and Non-small Cell Lung Cancer: Survival and Toxicity of Antineoplastic Chemotherapy in a Cohort Study

  2011cited by this paper
• Influenza and HIV: Lessons from the 2009 H1N1 Influenza Pandemic

  2011cited by this paper
• British HIV Association guidelines for the treatment of TB/HIV coinfection 2011

  2011cited by this paper
• Immunogenicity of a monovalent 2009 influenza A (H1N1) vaccine in an immunocompromised population: a prospective study comparing HIV-infected adults with HIV-uninfected adults.

  2011cited by this paper
• Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study

  2011cited by this paper
• Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis.

  2011cited by this paper
• Kinetics of serum β-D-glucan after Pneumocystis pneumonia treatment in patients with AIDS.

  2011cited by this paper
• Role of PCR for diagnosing Pneumocystis jirovecii pneumonia in HIV-infected individuals in a tertiary care hospital in India.

  2011cited by this paper
• HIV infection in the etiology of lung cancer: confounding, causality, and consequences.

  2011cited by this paper
• Pneumocystis infection and the pathogenesis of chronic obstructive pulmonary disease

  2011cited by this paper
• HIV and chronic obstructive pulmonary disease: is it worse and why?

  2011cited by this paper
• Infección por el virus de la inmunodeficiencia humana en diferentes grupos de edad: implicaciones potenciales para la prevención. Cohorte CoRIS, España, 2004–2008

  2010cited by this paper
• Influenza A Pandemic (H1N1) 2009 Virus and HIV

  2010cited by this paper
• Prevalence of dihydropteroate synthase genotypes before and after the introduction of combined antiretroviral therapy and their influence on the outcome of Pneumocystis pneumonia in HIV-1-infected patients.

  2010cited by this paper
• [Epidemiology of HIV infection through cohort studies: a look on the past in order to influence on the future].

  2010cited by this paper
• Non–AIDS-Defining Malignancies in Patients with HIV in the HAART Era

  2010cited by this paper
• Timing of initiation of antiretroviral drugs during tuberculosis therapy.

  2010cited by this paper
• Changes in cancer mortality among HIV-infected patients: the Mortalité 2005 Survey.

  2009cited by this paper
• HIV infection and the risk of cancers with and without a known infectious cause

  2009cited by this paper
• Respiratory Symptoms and Airway Obstruction in HIV-Infected Subjects in the HAART Era

  2009cited by this paper
• [Malignancies in HIV infected patients: study of 139 cases].

  2009cited by this paper
• A Meta-Analysis of the Incidence of Non-AIDS Cancers in HIV-Infected Individuals

  2009cited by this paper
• Effect of Simultaneous Use of Highly Active Antiretroviral Therapy on Survival of HIV Patients With Tuberculosis

  2009cited by this paper
• [Neoplasms and HIV in the epidemic's third decade].

  2009cited by this paper
• Natural history of HIV-associated pulmonary arterial hypertension: trends in the HAART era

  2008cited by this paper
• Prevención de las infecciones oportunistas en pacientes adultos y adolescentes infectados por el VIH en el año 2008 Recomendaciones del Grupo de Estudio del Sida (GESIDA)/ Plan Nacional sobre el Sida

  2008cited by this paper
• Cancer risk in people infected with human immunodeficiency virus in the United States

  2008cited by this paper
• Normal chest radiography in pulmonary tuberculosis: implications for obtaining respiratory specimen cultures.

  2008cited by this paper
• Pulmonary Arterial Hypertension in France: Results from a National Registry

  2007cited by this paper
• The impact of highly active antiretroviral therapy on non-AIDS-defining cancers among adults with AIDS.

  2007cited by this paper
• Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis.

  2007cited by this paper
• Serum indicators for the diagnosis of pneumocystis pneumonia.

  2007cited by this paper
• HIV infection is associated with an increased risk for lung cancer, independent of smoking.

  2007cited by this paper
• Lung cancer in HIV infected patients: facts, questions and challenges

  2006cited by this paper
• An Official ATS Workshop Summary: Recent advances and future directions in pneumocystis pneumonia (PCP).

  2006cited by this paper
• Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control

  2006cited by this paper
• Delayed Diagnosis and Elevated Mortality in an Urban Population With HIV and Lung Cancer: Implications for Patient Care

  2006cited by this paper
• Lung cancer, a new challenge in the HIV-infected population.

  2006cited by this paper
• Incidence of Tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America.

  2005cited by this paper
• A prospective, blinded study of quantitative touch-down polymerase chain reaction using oral-wash samples for diagnosis of Pneumocystis pneumonia in HIV-infected patients.

  2004cited by this paper
• Dihydropteroate Synthase Gene Mutations in Pneumocystis and Sulfa Resistance

  2004cited by this paper
• HIV-related lung cancer in the era of highly active antiretroviral therapy

  2003cited by this paper
• Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population.

  2003cited by this paper
• Non-AIDS-defining cancer in HIV-infected people.

  2003cited by this paper
• HIV-Related pulmonary hypertension: analytic review of 131 cases.

  2000cited by this paper
• Decreased antioxidant defence in individuals infected by the human immunodeficiency virus

  2000cited by this paper
• Epoprostenol (prostacyclin) therapy in HIV-associated pulmonary hypertension.

  2000cited by this paper
• Epidemiologic Relation between HIV and Invasive Pneumococcal Disease in San Francisco County, California

  2000cited by this paper
• The pathophysiology of pulmonary diffusion impairment in human immunodeficiency virus infection.

  1999cited by this paper
• Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection. EuroSIDA Study Group.

  1999cited by this paper
• Comparison of molecular changes in lung cancers in HIV-positive and HIV-indeterminate subjects.

  1998cited by this paper
• An RGD containing peptide from HIV-1 Tat-(65-80) modulates protooncogene expression in human bronchoalveolar carcinoma cell line, A549.

  1997cited by this paper
• Variation of chest radiographic patterns in pulmonary tuberculosis by degree of human immunodeficiency virus-related immunosuppression. The Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA). The AIDS Clinical Trials Group (ACTG).

  1997cited by this paper
• The Laboratory Evaluation of Opportunistic Pulmonary Infections

  1996cited by this paper
• Survival in Primary Pulmonary Hypertension with Long-Term Continuous Intravenous Prostacyclin

  1994cited by this paper
• Both immunity and hyperresponsiveness to Pneumocystis carinii result from transfer of CD4+ but not CD8+ T cells into severe combined immunodeficiency mice.

  1992cited by this paper
• New serum indicator of interstitial pneumonitis activity. Sialylated carbohydrate antigen KL-6.

  1989cited by this paper

• No citing papers are available for this paper.